These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

440 related items for PubMed ID: 28062257

  • 1. Liraglutide prevents cognitive decline in a rat model of streptozotocin-induced diabetes independently from its peripheral metabolic effects.
    Palleria C, Leo A, Andreozzi F, Citraro R, Iannone M, Spiga R, Sesti G, Constanti A, De Sarro G, Arturi F, Russo E.
    Behav Brain Res; 2017 Mar 15; 321():157-169. PubMed ID: 28062257
    [Abstract] [Full Text] [Related]

  • 2. Liraglutide ameliorates cognitive decline by promoting autophagy via the AMP-activated protein kinase/mammalian target of rapamycin pathway in a streptozotocin-induced mouse model of diabetes.
    Kong FJ, Wu JH, Sun SY, Ma LL, Zhou JQ.
    Neuropharmacology; 2018 Mar 15; 131():316-325. PubMed ID: 29305122
    [Abstract] [Full Text] [Related]

  • 3. The neuroprotection of liraglutide on diabetic cognitive deficits is associated with improved hippocampal synapses and inhibited neuronal apoptosis.
    Yan W, Pang M, Yu Y, Gou X, Si P, Zhawatibai A, Zhang Y, Zhang M, Guo T, Yi X, Chen L.
    Life Sci; 2019 Aug 15; 231():116566. PubMed ID: 31201846
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of the effects of liraglutide on the development of epilepsy and behavioural alterations in two animal models of epileptogenesis.
    Citraro R, Iannone M, Leo A, De Caro C, Nesci V, Tallarico M, Abdalla K, Palma E, Arturi F, De Sarro G, Constanti A, Russo E.
    Brain Res Bull; 2019 Nov 15; 153():133-142. PubMed ID: 31470253
    [Abstract] [Full Text] [Related]

  • 5. Reduction in TNF alpha and oxidative stress by liraglutide: Impact on ketamine-induced cognitive dysfunction and hyperlocomotion in rats.
    Sedky AA, Magdy Y.
    Life Sci; 2021 Aug 01; 278():119523. PubMed ID: 33891942
    [Abstract] [Full Text] [Related]

  • 6. Minocycline reverses diabetes-associated cognitive impairment in rats.
    Mehta BK, Banerjee S.
    Pharmacol Rep; 2019 Aug 01; 71(4):713-720. PubMed ID: 31207433
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The neuroprotection of liraglutide on Alzheimer-like learning and memory impairment by modulating the hyperphosphorylation of tau and neurofilament proteins and insulin signaling pathways in mice.
    Xiong H, Zheng C, Wang J, Song J, Zhao G, Shen H, Deng Y.
    J Alzheimers Dis; 2013 Aug 01; 37(3):623-35. PubMed ID: 24008687
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The GLP-1 Receptor Agonist Liraglutide Improves Memory Function and Increases Hippocampal CA1 Neuronal Numbers in a Senescence-Accelerated Mouse Model of Alzheimer's Disease.
    Hansen HH, Fabricius K, Barkholt P, Niehoff ML, Morley JE, Jelsing J, Pyke C, Knudsen LB, Farr SA, Vrang N.
    J Alzheimers Dis; 2015 Aug 01; 46(4):877-88. PubMed ID: 25869785
    [Abstract] [Full Text] [Related]

  • 11. Neurobehavioral effects of liraglutide and sitagliptin in experimental models.
    Kamble M, Gupta R, Rehan HS, Gupta LK.
    Eur J Pharmacol; 2016 Mar 05; 774():64-70. PubMed ID: 26849938
    [Abstract] [Full Text] [Related]

  • 12. Metabolic and Cognitive Effects of Ranolazine in Type 2 Diabetes Mellitus: Data from an in vivo Model.
    Cassano V, Leo A, Tallarico M, Nesci V, Cimellaro A, Fiorentino TV, Citraro R, Hribal ML, De Sarro G, Perticone F, Sesti G, Russo E, Sciacqua A.
    Nutrients; 2020 Jan 31; 12(2):. PubMed ID: 32023991
    [Abstract] [Full Text] [Related]

  • 13. Resveratrol prevents cognitive deficits by attenuating oxidative damage and inflammation in rat model of streptozotocin diabetes induced vascular dementia.
    Gocmez SS, Şahin TD, Yazir Y, Duruksu G, Eraldemir FC, Polat S, Utkan T.
    Physiol Behav; 2019 Mar 15; 201():198-207. PubMed ID: 30550811
    [Abstract] [Full Text] [Related]

  • 14. Aliskiren and captopril improve cognitive deficits in poorly controlled STZ-induced diabetic rats via amelioration of the hippocampal P-ERK, GSK3β, P-GSK3β pathway.
    Youssef MM, Abd El-Latif HA, El-Yamany MF, Georgy GS.
    Toxicol Appl Pharmacol; 2020 May 01; 394():114954. PubMed ID: 32171570
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The novel GLP-1/GIP dual agonist DA3-CH is more effective than liraglutide in reducing endoplasmic reticulum stress in diabetic rats with cerebral ischemia-reperfusion injury.
    Bai B, Li D, Xue G, Feng P, Wang M, Han Y, Wang Y, Hölscher C.
    Nutr Metab Cardiovasc Dis; 2021 Jan 04; 31(1):333-343. PubMed ID: 33500109
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. GLP-1 analog liraglutide protects against cardiac steatosis, oxidative stress and apoptosis in streptozotocin-induced diabetic rats.
    Inoue T, Inoguchi T, Sonoda N, Hendarto H, Makimura H, Sasaki S, Yokomizo H, Fujimura Y, Miura D, Takayanagi R.
    Atherosclerosis; 2015 May 04; 240(1):250-9. PubMed ID: 25818251
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.